| 000 | 01864 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514231432.0 | ||
| 264 | 0 | _c20051006 | |
| 008 | 200510s 0 0 eng d | ||
| 022 | _a0934-0874 | ||
| 024 | 7 |
_a10.1111/j.1432-2277.2005.00145.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarkholt, Lisbeth | |
| 245 | 0 | 0 |
_aOKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation. _h[electronic resource] |
| 260 |
_bTransplant international : official journal of the European Society for Organ Transplantation _cJul 2005 |
||
| 300 |
_a835-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCytomegalovirus _xgenetics |
| 650 | 0 | 4 |
_aDNA, Viral _xantagonists & inhibitors |
| 650 | 0 | 4 | _aEpstein-Barr Virus Infections |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGanciclovir _xtherapeutic use |
| 650 | 0 | 4 | _aGene Dosage |
| 650 | 0 | 4 | _aGenome, Viral |
| 650 | 0 | 4 |
_aHepatitis, Viral, Human _xvirology |
| 650 | 0 | 4 |
_aHerpesvirus 4, Human _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
| 650 | 0 | 4 |
_aLymphoma _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuromonab-CD3 _xadverse effects |
| 650 | 0 | 4 | _aPostoperative Period |
| 650 | 0 | 4 |
_aTacrolimus _xadverse effects |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 |
_aViremia _xetiology |
| 700 | 1 | _aLinde, Annika | |
| 700 | 1 | _aFalk, Kerstin I | |
| 773 | 0 |
_tTransplant international : official journal of the European Society for Organ Transplantation _gvol. 18 _gno. 7 _gp. 835-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1432-2277.2005.00145.x _zAvailable from publisher's website |
| 999 |
_c15608454 _d15608454 |
||